C-reactive Protein as an Indicator for Antidepressant Response in Late-Onset Depression

Area of Science:

• Geriatric Psychiatry
• Neuroscience
• Immunology

Background:

• Late-onset depression presents unique pathophysiological characteristics compared to early-onset depression.
• Factors such as immune dysfunction, atherosclerosis, and vascular issues contribute to late-onset depression.
• Inflammatory markers are hypothesized to influence antidepressant therapy response in this population.

Purpose of the Study:

• To investigate the association between inflammatory marker levels and antidepressant therapy response in individuals with late-onset depression.
• To evaluate the efficacy of standard antidepressant treatment in a cohort of elderly patients experiencing their first depressive episode.

Main Methods:

• Recruited individuals aged over 60 with their first depressive episode.
• Assessed baseline depression severity (Hamilton Depression Rating Scale), and C-reactive protein (CRP) levels.
• Followed patients for eight weeks of antidepressant treatment, reassessing depression severity.

Main Results:

• The study included 25 participants with a mean age of 64.7 years.
• The overall antidepressant response rate was low at 24%.
• A significant negative correlation was found between baseline CRP levels and antidepressant responsiveness (r = -0.6, p < 0.05).

Conclusions:

• Late-onset depression demonstrates limited responsiveness to standard antidepressant medication.
• Elevated baseline C-reactive protein levels are associated with a poorer response to antidepressant therapy in late-onset depression.
• Inflammation may play a critical role in the therapeutic resistance observed in this patient group.